Affiliated Yongkang First People's Hospital and School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 310012, China.
Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, Jilin, 133002, China.
Int J Biol Sci. 2023 Jun 19;19(10):3249-3265. doi: 10.7150/ijbs.81900. eCollection 2023.
Microglia-mediated neuroinflammation is closely related to the development of Alzheimer's disease (AD). In the early stages of the inflammation response, pattern recognition receptors (PRRs) play a key role in clearing damaged cells and defending against infection by recognizing endogenous and exogenous ligands. However, the regulation of pathogenic microglial activation and its role in AD pathology remains poorly understood. Here we showed that a pattern recognition receptor called Dectin-1, expressed on microglia, mediates the pro-inflammatory responses of beta-amyloid (Aβ). Knockout of Dectin-1 reduced Aβ1-42 (Aβ)-induced microglial activation, inflammatory responses, and synaptic and cognitive deficits in Aβ-infused AD mice. Similar results were obtained in the BV2 cell model. Mechanistically, we showed that Aβ could directly bind to Dectin-1, causing Dectin-1 homodimerization and activating downstream spleen tyrosine kinase (Syk)/nuclear factor-κB (NF-κB) signaling pathway to induce the expression of inflammatory factors and, in turn, AD pathology. These results suggest the important role of microglia Dectin-1 as a new direct receptor for Aβ in microglial activation and AD pathology and provide a potential therapeutic strategy for neuroinflammation in AD.
小胶质细胞介导的神经炎症与阿尔茨海默病(AD)的发展密切相关。在炎症反应的早期阶段,模式识别受体(PRRs)通过识别内源性和外源性配体,在清除受损细胞和抵御感染方面发挥关键作用。然而,致病小胶质细胞激活的调节及其在 AD 病理中的作用仍知之甚少。在这里,我们表明,一种称为 Dectin-1 的模式识别受体在小胶质细胞上表达,介导β-淀粉样蛋白(Aβ)的促炎反应。Dectin-1 敲除减少了 Aβ1-42(Aβ)诱导的小胶质细胞激活、炎症反应以及 Aβ 输注 AD 小鼠的突触和认知缺陷。在 BV2 细胞模型中也得到了类似的结果。在机制上,我们表明 Aβ可以直接与 Dectin-1 结合,导致 Dectin-1 同源二聚化并激活下游脾酪氨酸激酶(Syk)/核因子-κB(NF-κB)信号通路,诱导炎症因子的表达,并进而导致 AD 病理。这些结果表明小胶质细胞 Dectin-1 作为 Aβ在小胶质细胞激活和 AD 病理中的新直接受体的重要作用,并为 AD 中的神经炎症提供了一种潜在的治疗策略。